SARS-CoV-2 infection can block pain, opening up unexpected new possibilities for research into pain relief medication

The SARS-CoV-2 virus usually infects the body via the ACE2 protein. But there is another entry point that allows the virus to infect the nervous system and block pain perception.

View of Post-COVID pain syndrome Anaesthesia, Pain & Intensive Care

Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care - The Lancet Respiratory Medicine

Two Years into the COVID-19 Pandemic: Lessons Learned

Drug Discovery Strategies for SARS-CoV-2 Journal of Pharmacology and Experimental Therapeutics

Researchers recruit study participants for treatment of long COVID - University of Mississippi Medical Center

Natural products as a source of novel drugs for treating SARS-CoV2 infection - ScienceDirect

Mutations in spike protein of SARS-CoV-2 pirola variant found to augment infection of lung cells

IJERPH, Free Full-Text

Is Muscle Pain a Symptom of the Coronavirus?

Could Paxlovid Treat Long COVID? - The Atlantic